LAG3 and B-cell non-Hodgkin lymphoma: In this retrospective observational study, we analyzed treatment outcomes in B-cell lymphoma patients after CAR-T cell therapy according to the germline LAG3 gene variants (LAG3 I455hom, I455Thet, T455hom).